Compare CADL & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | PUBM |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.6M | 587.5M |
| IPO Year | 2021 | 2020 |
| Metric | CADL | PUBM |
|---|---|---|
| Price | $10.65 | $17.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $19.00 | $12.43 |
| AVG Volume (30 Days) | ★ 1.1M | 598.8K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $125,000.00 | ★ $282,926,000.00 |
| Revenue This Year | N/A | $3.44 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $6.15 |
| 52 Week High | $11.36 | $18.44 |
| Indicator | CADL | PUBM |
|---|---|---|
| Relative Strength Index (RSI) | 60.63 | 78.45 |
| Support Level | $9.18 | $8.85 |
| Resistance Level | $11.36 | N/A |
| Average True Range (ATR) | 0.47 | 0.61 |
| MACD | 0.04 | 0.50 |
| Stochastic Oscillator | 87.00 | 85.00 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.